Oxaliplatino Accord 5 mg/ml concentrato per soluzione per infusione
Sponsors
Fondazione IRCCS Istituto Nazionale Dei Tumori, IRCCS Istituto Nazionale Tumori Fondazione Pascale
Conditions
Patients with ras-mutated metastatIc colorectal cancercolorectal cancer
Phase 2
Phase II study of adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) for the prevention of peritoneal metastases after curative-intent surgery for high-risk colorectal cancer.
RecruitingCTIS2024-513376-17-00
Start: 2020-11-24Target: 30Updated: 2024-06-18
REVOLUTION - Randomized phasE 2 study of Valproic acid in combination with bevacizumab and Oxaliplatin/fLUoropyrimidine regimens in patients with ras-mutated metastaTIc cOlorectal caNcer
Active, not recruitingCTIS2024-516844-25-01
Start: 2019-01-03Target: 200Updated: 2025-07-22